31.20 (-%)
As of Nov 21, 2024
Source:
Akero Therapeutics, Inc is a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, including non-alcoholic steatohepatitis, or NASH, a disease without any approved therapies.
| Country | United States |
| Headquarters | south san francisco, california |
| Phone Number | 650-487-6488 |
| Industry | manufacturing |
| CEO | Andrew Cheng |
| Website | www.akerotx.com |